المملكة: "Food and medicine" The first local clinical study for leukemia is adopted
I released The Food and Drug General Authority its approval of the first clinical study from the first stage of an innovative genetic treatment that was locally developed using CAR T-Cells under the title "A study in the first stage using the receptors of the gym for T -cells to treat adult patients with acute acute lymphocyclacia for protein (CD19), who were exposed to a setback or did not respond to treatment, using a closed transmission system. National, using a closed system within an advanced manufacturing unit at King Faisal Specialist Hospital and Research Center in Riyadh, to confirm the integrative efforts between the regulatory and research authorities in developing advanced treatments within the Kingdom." target ="_Blank"> The blood lymphatic lymphatic (all) is one of the most severe types of blood tumors, bone marrow and speed in growth, as it affects the white lymphocytes and pushes the bone marrow to produce large quantities of immature cells, which leads to the crowding of normal cells and weakens the body’s ability to resist infection, transmit oxygen and stop bleeding. T cells of the patient outside the body to re -program them on targeting protein -bearing tumor cells (CD19) and then re -injection to the patient; The study aims to assess the safety of treatment as it is a major goal in this early stage. "Let’s produce/Melitoni" Within a specialized internal manufacturing unit, using a closed transportation system with the aim of ensuring the safety of the preparation on patients from the age of 18 to 60 years, as it is given by venous injection. It contributes to accelerating the availability of promising treatments.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
